As humanity prepares for long-duration space missions, one of the greatest obstacles lies not only in rockets and satellites but in our own biology. Space travel exposes the human body to unique challenges, including microgravity, hypo-gravity and cosmic radiation, which accelerate aging and cause organ damage.
This conference will bring together leading experts to explore cutting-edge research and innovations that could make extended space travel a reality while shedding light on the invaluable lessons space biology offers for life on Earth. From addressing age-related conditions to tackling kidney disease to preserving brain function, the physiological insights gained from space are driving breakthroughs in healthcare here at home.
This is a conference aimed at showcasing how space biology is driving biotech breakthroughs and how life sciences can be leveraged to drive the Space Health agenda. It will be held at the Babraham Research Campus, a major life sciences research and innovation campus in Cambridge, UK.
The event is being organised by LinkGevity, a Cambridge-based, AI-enabled drug discovery company focused on aging and age-related deterioration, and Delta Biosciences, a developer of ultra-miniaturized screening technologies for drug discovery and space health applications. The strategic partners of the conference are the UK Space Agency and Space East.